<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05059678</url>
  </required_header>
  <id_info>
    <org_study_id>2021-0380</org_study_id>
    <secondary_id>NCI-2021-09153</secondary_id>
    <secondary_id>2021-0380</secondary_id>
    <secondary_id>R21CA256694</secondary_id>
    <nct_id>NCT05059678</nct_id>
  </id_info>
  <brief_title>Parenting Support Intervention for Families Coping With Metastatic or Locally Recurrent Solid Tumor Diagnosis</brief_title>
  <official_title>Parenting Support Intervention for Families Coping With an Advanced Cancer Diagnosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical trial examines the acceptability and effect of a parenting support intervention&#xD;
      for families coping with solid tumor that has spread to other places in the body (metastatic)&#xD;
      or has come back (recurrent). Parenting support program may help to reduce common parenting&#xD;
      concerns, improve communication between parents and children about cancer, and improve the&#xD;
      overall psychological wellbeing of parents.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:&#xD;
&#xD;
      I. Examine the acceptability a parenting support intervention in 10 patients with an&#xD;
      incurable cancer and their spousal caregivers. (Trial 1) II. Examine the feasibility of&#xD;
      implementing a parenting support intervention in 50 patients with an incurable cancer and&#xD;
      their spousal caregivers. (Trial 2) III. Evaluate the initial evidence for intervention&#xD;
      efficacy relative to waitlist control (WLC) group regarding patient and spousal caregiver&#xD;
      psychological symptoms (primary outcome) and parenting concerns and parenting efficacy&#xD;
      (secondary outcomes) and patient end of life (EOL) healthcare utilization (exploratory&#xD;
      outcome). (Trial 2) IV. Understand the patients and caregivers' experiences using qualitative&#xD;
      methods regarding participation in this study and explore emerging themes as possible&#xD;
      intervention mediators/moderators to be examined in future research. (Trial 2)&#xD;
&#xD;
      OUTLINE:&#xD;
&#xD;
      TRIAL 1: Participants receive education materials (brochure and a video) and attend 2 weekly&#xD;
      videoconference intervention sessions over 45 minutes each. Caregivers attend 2 additional&#xD;
      weekly intervention sessions over 45 minutes each.&#xD;
&#xD;
      TRIAL 2: Participants are randomized to 1 of 2 groups.&#xD;
&#xD;
      GROUP I: Participants receive education materials (brochure and a video) and attend 2 weekly&#xD;
      videoconference intervention sessions over 45 minutes each. Caregivers attend 2 additional&#xD;
      weekly intervention sessions over 45 minutes each.&#xD;
&#xD;
      GROUP II: Participants receive standard of care.&#xD;
&#xD;
      After completion of study, participants in Trial 1 are followed up at 6 and 12 weeks and&#xD;
      participants in Trial 2 are followed up at 12 weeks.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 13, 2022</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Examine the feasibility of implementing a parenting support intervention in 50 patients with an incurable cancer and their spousal caregivers.</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Metastatic Malignant Solid Neoplasm</condition>
  <condition>Recurrent Malignant Solid Neoplasm</condition>
  <arm_group>
    <arm_group_label>Group I (education material, videoconference session)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive education materials (brochure and a video) and attend 2 weekly videoconference intervention sessions over 45 minutes each. Caregivers attend 2 additional weekly intervention sessions over 45 minutes each.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II (waitlist control)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants receive standard of care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Best Practice</intervention_name>
    <description>Receive standard of care</description>
    <arm_group_label>Group II (waitlist control)</arm_group_label>
    <other_name>standard of care</other_name>
    <other_name>standard therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Educational Intervention</intervention_name>
    <description>Receive educational materials and attend videoconference sessions</description>
    <arm_group_label>Group I (education material, videoconference session)</arm_group_label>
    <other_name>Education for Intervention</other_name>
    <other_name>Intervention by Education</other_name>
    <other_name>Intervention through Education</other_name>
    <other_name>Intervention, Educational</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Group I (education material, videoconference session)</arm_group_label>
    <arm_group_label>Group II (waitlist control)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients must be diagnosed with a metastatic or locally recurrent solid malignant&#xD;
             tumor&#xD;
&#xD;
          -  Patients must be at least 18 years old&#xD;
&#xD;
          -  Patients must have at least one dependent child between the ages of 4 and 12 and&#xD;
             currently living with the parent&#xD;
&#xD;
          -  Patients must be able to provide informed consent&#xD;
&#xD;
          -  Patients must have a spousal caregiver over the age of 18 who co-parents the&#xD;
             child(ren) (i.e. share custody) and is willing and able to consent to participate&#xD;
&#xD;
          -  Patients with cognitive deficits that would impede the completion of self-report&#xD;
             instruments as measured by the Mini Mental State Examination (score of =&lt; 17)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients and caregivers who do not read and speak English and who do not have access&#xD;
             to the internet&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kathrin Milbury</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kathrin Milbury</last_name>
    <phone>713-745-2868</phone>
    <email>kmilbury@mdanderson.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Kathrin Milbury</last_name>
      <phone>713-745-2868</phone>
      <email>kmilbury@mdanderson.org</email>
    </contact>
    <investigator>
      <last_name>Kathrin Milbury</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>M.D. Anderson Cancer Center</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 10, 2021</study_first_submitted>
  <study_first_submitted_qc>September 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2021</study_first_posted>
  <last_update_submitted>October 6, 2021</last_update_submitted>
  <last_update_submitted_qc>October 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

